MedPath

Effects of rosuvastatin and sevelamer in coronary calcification in chronic kidney disease patients

Phase 4
Conditions
Coronary calcification
Registration Number
RBR-6pngwz
Lead Sponsor
IVERSIDADE FEDERAL DE SAO PAULO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
other
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

All patients were older than 18 years and were followed by a nephrologist for at least 03 months.

Exclusion Criteria

Exclusion criteria were the presence of chronic inflammatory diseases, active malignancy, human immunodeficiency virus (HIV), viral hepatitis and chronic steroids intake.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Coronary calcification progression, determined by coronary tomography at study baseline and after follow up period.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath